Press Releases GSK plc Deutsche Boerse AG

Equities

GS71

GB00BN7SWP63

Market Closed - Deutsche Boerse AG Other stock markets 20:49:18 07/05/2024 BST			5-day change	1st Jan Change
20.41 ^EUR	+2.85%		+6.03%	+22.33%

05-07	GSK acquires stake in Swiss BioVersys	CF
05-07	DZ Bank Keeps GSK at Hold, Raises PT	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million	05-07	AQ
GSK : Q1 2024 results transcript	05-02	PU
GSK : Q1 2024 results slides	05-02	PU
GSK : Q1 2024 results infographic	05-02	PU
Glaxo: Q1 Earnings Snapshot	05-01	AQ
US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer \| GSK	04-24	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	04-19	PU
EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments \| GSK	04-17	AQ
New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade \| GSK	04-17	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments - Form 6-K	04-17	PU
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA \| GSK	04-17	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments	04-17	PU
GSK : New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade	04-17	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA - Form 6-K	04-16	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA	04-16	PU
GSK : Q1 2024 pre announcement aide memoire	04-11	PU
WuXi Biologics Reports Solid 2023 Annual Results	03-27	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	03-22	PU
Haleon to buy shares from Pfizer as US pharma giant reduces its stake	03-19	AQ
GSK plc - Positive RUBY phase III data show potential for Jemperli combinations in more patients with primary advanced or recurrent endometrial cancer	03-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK plc : Back on track

May 03, 2024 at 10:17 am

GSK PLC : Encouraging start to 2024; guidance raised

May 01, 2024 at 04:38 pm